During the past decade, Gynekologie MU Dr.Lubomir Mikulasek / ID # 160 conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Gynekologie MU Dr.Lubomir Mikulasek / ID # 160" are "Endometriosis" (2 trials). Many other conditions were trialed in "Gynekologie MU Dr.Lubomir Mikulasek / ID # 160" in a lesser frequency.

Most popular intervention types in "Gynekologie MU Dr.Lubomir Mikulasek / ID # 160" are "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "200 mg linzagolix tablet" (2 trials), "75 mg linzagolix tablet" (2 trials), "Add-back capsule (E2 1 mg / NETA 0.5 mg)" (2 trials), "Placebo capsule to match Add-back capsule" (2 trials) and "Placebo tablet to match 200 mg linzagolix tablet" (2 trials). Other intervention names were less common.

The vast majority of trials in "Gynekologie MU Dr.Lubomir Mikulasek / ID # 160" are 2 trials for "Female" genders.

Currently, there are NaN active trials in "Gynekologie MU Dr.Lubomir Mikulasek / ID # 160". undefined are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Gynekologie MU Dr.Lubomir Mikulasek / ID # 160, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Gynekologie MU Dr.Lubomir Mikulasek / ID # 160, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".